This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order valued at $85,586.62 for the supply of 4,564,640,389 dosages of the drug Droxidopa 100 mg capsules. The contract has an ultimate completion date of May 20, 2024 and is a Firm Fixed Price agreement.
Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, leveraging its extensive supply chain network as a subsidiary of Amerisourcebergen Corporation. The company holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a wide range of medical commodities to the Department of Defense worldwide. Additionally, Amerisourcebergen holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
This contract award does not have a set-aside designation, indicating it was competed on a full and open basis. The DLA is the funding agency, responsible for providing logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies.
Generated 8/16/24, 9:39 AM